Creative Biostructure to Present at AACR Annual Meeting 2024 | April 5-10, 2024 | Booth #2953 
COVID-19 B1.1.529(Omicron) VLP (M; N; S; E Proteins)(CBS-V962)
Inquiry
| Product Summary | |
|---|---|
| Name | COVID-19 B1.1.529(Omicron) VLP (M; N; S; E Proteins) |
Download Datasheet
|
|
| Cat No. | CBS-V962 |
| Source | HEK293 |
| Virus Name | SARS-CoV-2 |
| Virus Family | Coronaviridae |
| Composition | M; N; S; E Proteins |
| Purity | >85% |
| Presentation | Phosphate Buffered Saline, pH 7.4. |
| Description | SARS-CoV-2 virus-like particles B.1.1.529 (Omicron) are composed of four structural proteins: Membrane protein (M), Nucleocapsid protein (N), Omicron-spike protein (S) and Envelope protein (E). VLPs are produced in mammalian HEK293 cells. |
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Frequently Asked Questions
-
What expression systems do you use for your VLP products?
Our virus-like particles are produced from different expression systems such as E. coli, yeast, insect cells, and HEK293 cells.
